The QualityStocks Daily Wednesday, December 1st, 2021

Today's Top 3 Investment Newsletters

MarketClub Analysis(ABUS) $4.6100 +44.06%

QualityStocks(VFRM) $0.0417 +36.56%

InvestorBrandNetwork(IWBB) $4.8000 +21.52%

The QualityStocks Daily Stock List

Rare Element Resources Ltd. (REEMF)

MarketBeat, QualityStocks, TradersPro and InvestorIntel reported earlier on Rare Element Resources Ltd. (REEMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rare Element Resources Ltd. is a mineral resource company based in Littleton, Colorado. The Company is focusing on delivering strategic materials to technology industries by advancing plans to develop the Bear Lodge Critical Rare Earth Project in northeast Wyoming. It owns a 100 percent interest in a group of 499 unpatented mining claims and 640 acres owned in patent. The mine site is about 12 miles northwest of the town of Sundance, Wyoming. Rare Element Resources’ shares trade on the OTCQB.

Additionally, Rare Element Resources has an option on a parcel of land positioned on the outskirts of the town of Upton, Wyoming, around 40 miles to the southwest. This is the planned site for the Project's hydrometallurgical processing plant.

Extensive geological work by Rare Element Resources since 2004, including drilling, geophysical and geochemical sampling and assaying, has resulted in a Measured & Indicated resource of 18 million tons grading 3.05% Total Rare Earth Oxide (TREO) at a 1.5% cut-off grade for the Bear Lodge Project. This includes 3.0 million tons of Measured and 15 million tons of Indicated resource.

The Bear Lodge Project is located in one of the best mining districts in the world. The Project is rich in “critical rare earths” (CREE), those elements that are less common, higher valued and expected to experience better demand growth and price support over the long term.

Regarding Rare Earths at the Bear Lodge Project, the deposits there contain 10 rare earth elements. Of these, five are identified as "critical" in the Department of Energy, Critical Materials Strategy Report published in 2011. These five element plus praseodymiun, that the Company includes due to its ability to be substituted for Neodymiun in high intensity permanent magnets, are expected to account for greater than 80 percent of the Project's projected revenues.

Rare Element Resources previously announced major progress on the third-party test work relating to its proprietary rare earth separation technology being conducted by Umwelt-und Ingenieurtechnik GmbH Dresden (UIT). UIT is an affiliate of Synchron, a significant shareholder of the Company. Rare Element Resources engaged UIT in April of 2018 to validate and further enhance its proprietary rare earth element processing technology.

UIT has advanced mineral and materials research capabilities in Dresden, Germany. UIT reported that its test work successfully validated Rare Element Resources’ proprietary technology and process flowsheet and identified additional opportunities for improvement.

Rare Element Resources Ltd. (REEMF), closed Wednesday’s trading session at $1.217, up 35.7994%, on 539,801 volume with 521 trades. The average volume for the last 3 months is 539,801 and the stock's 52-week low/high is $0.50/$4.13.

Arbutus Biopharma (ABUS)

MarketClub Analysis, MarketBeat, BUYINS.NET, StockMarketWatch,, TraderPower, Daily Trade Alert, Trades Of The Day, Schaeffer's, Zacks, TradersPro, StreetInsider, QualityStocks, Profitable Trader Authority, InvestorsUnderground, Money Morning, OTCtipReporter, Barchart, PennyStockScholar, Streetwise Reports, The Street and PennyStockProphet reported earlier on Arbutus Biopharma (ABUS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Arbutus Biopharma Corporation (NASDAQ: ABUS) (FRA: 19DN) is a biopharmaceutical firm that is focused on discovering, developing and commercializing cures for patients who suffer from the HBV infection in the U.S. (chronic Hepatitis B virus).

The firm has its headquarters in Warminster, Pennsylvania and was incorporated in 2007. Prior to its name change in July 2015, the firm was known as Tekmira Pharmaceuticals Corporation. It operates in the healthcare sector, under the biotech and pharma sub-industry and serves consumers in Canada and the U.S. The firm’s subsidiaries include Arbutus Biopharma US Holdings Inc. and Arbutus Inc.

The company’s objective is to develop a curative combination regiment for the chronic Hepatitis B virus infection and formulate a suite of products that intervene at various points in the virus’ life cycle and reactivate the host’s immune system. The company is also involved in the licensing of lipid nanoparticle technology. It is party to research collaboration, licensing and alliance agreements with Acuitas Therapeutics Inc., Alnylam Pharmaceuticals Inc., Gritstone Oncology Inc. and Marqibo.

The enterprise’s product pipeline includes an oral capsid inhibitor dubbed AB-836 indicated for HBV DNA replication suppression and a subcutaneously-delivered RNA candidate dubbed AB-729, which decreases HBV antigens through the use of GalNAc delivery technology and is currently undergoing a phase 1 clinical trial. The enterprise also has research and development programs, including an oral PD-L1 inhibitor that reawakens patients HBV immune response and HBV RNA destabilizers.

The firm has over the last year managed to increase its revenue by roughly 10% and with the Hepatitis B treatment market set to grow, the firm may soon bring in even heftier returns, which will in turn bring in more investments.

Arbutus Biopharma (ABUS), closed Wednesday’s trading session at $4.61, up 44.0625%, on 322,127,014 volume with 1.01M trades. The average volume for the last 3 months is 322.127M and the stock's 52-week low/high is $2.43/$6.50.

Veritas Farms, Inc. (VFRM)

QualityStocks and SmallCapVoice reported earlier on Veritas Farms, Inc. (VFRM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Veritas Farms, Inc. is a vertically integrated agribusiness based in Fort Lauderdale, Florida. Its focus is on the production of full spectrum hemp oil products with naturally occurring cannabinoids. The Company was previously known as SanSal Wellness Holdings, Inc. It changed its name to Veritas Farms, Inc. in February of 2019. The Company lists on the OTC Markets Group’s OTCQB.

Presently, Veritas Farms owns and operates a 140-acre farm and production facility in Pueblo, Colorado. The Company is registered with the Colorado Department of Agriculture to grow industrial hemp.

Veritas markets and sells products under its Veritas Farms™ brand. Moreover, it manufactures private label products for several top distributors and retailers. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity.

Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications, as well as infused edibles. In addition, they include lotions, salves, and oral syringes in an array of size formats and flavors.

Veritas Farms has announced it is expanding its presence on its top-selling full spectrum hemp Lip Balm line of products. The Company’s Single Orange Cream Lip Balm is the top-selling topical CBD SKU in units according to IRI in the Food Class of Trade for the latest period (IRI Latest 13 Weeks Food). Across all channels, including chain Food and Drug, Orange Cream Lip Balm remains one of the overall top-selling items.

Veritas Farms previously announced that it entered into a Memorandum of Understanding (MOU) with Pure Research Products, LLC to access and incorporate the technology used in their Del-Immune V® brand of products to develop additional Veritas Farms full spectrum hemp oil products. Del-Immune V® and the Del-Immune line of dietary supplements use the probiotic strain Lacticaseibacillus rhamnosus (L. rhamnosus) [WF1] to increase immune function in the body.

It establishes a partnership with Pure Research to maximize the benefits of Veritas Farms’ product line via the research, development, and production of a Del-Immune V® enhanced line of full spectrum hemp oil products.

Veritas Farms, Inc. (VFRM), closed Wednesday’s trading session at $0.04165, up 36.5574%, on 1,227,643 volume with 63 trades. The average volume for the last 3 months is 1.228M and the stock's 52-week low/high is $0.0267/$0.352.

SusGlobal Energy Corp. (SNRG)

QualityStocks, SmallCapVoice and Five Star Stock Picks reported earlier on SusGlobal Energy Corp. (SNRG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SusGlobal Energy Corp. is the developer of SusGro™, which is a pioneering pathogen free organic fertilizer. The Company is a renewables business centered on acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application worldwide. SusGlobal Energy has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

SusGlobal Energy has the capability to provide a complete range of services for handling organic residuals. The Company has spent years attaining proprietary processes and combining different treatments. It also has many years of innovative experience and technical knowledge and thus can provide its clients with comprehensive solutions. SusGlobal Energy has projects in Belleville, Ontario; Hamilton, Ontario; and Florida.

SusGlobal Energy can, from beginning to end, offer in-depth knowledge, abundant experience and trailblazing technology for all a client’s needs in handling organic waste. Some of the Company’s work managing organic waste streams includes Anaerobic Digestion, Dry Digestion, Biogas Production, Wastewater Treatment, In-Vessel Composting, Source Separated Organics Treatment, Biosolids Heat Treatment and Composting.

The Company’s SusGro™ pathogen free organic fertilizer offers an economical, sustainable and highly effective alternative to traditional fertilization. SusGro™ is an organically-based, concentrated organic pathogen free liquid fertilizer product. It has a full complement of nutrients suitable for a broad spectrum of fertilization requirements.

In addition, SusGlobal Energy’s Earth’s Journey™ Compost enhances plant growth. The Company employs patented technology to transform organic waste into the most nutrient-rich organic compost, diverting organic waste from landfills and lessening Greenhouse Gas (GHG) emissions.

SusGlobal Energy Corp. (SNRG), closed Wednesday’s trading session at $0.28, up 33.3333%, on 548,088 volume with 62 trades. The average volume for the last 3 months is 548,088 and the stock's 52-week low/high is $0.045/$0.58.

ThermoGenesis Holdings (THMO)

BUYINS.NET, StockMarketWatch, QualityStocks and MarketClub Analysis reported earlier on ThermoGenesis Holdings (THMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ThermoGenesis Holdings Inc. (NASDAQ: THMO) (FRA: THRP) is a healthcare firm that is focused on the development, commercialization and marketing of various automated technologies for CAR-T therapies as well as other cell-based therapies.

The firm has its headquarters in Rancho Cordova, California and was incorporated in 1986 by Philip H. Coelho and David Demirjian. Prior to its name change in November 2019, the firm was known as Cesca Therapeutics Inc. It operates as part of the healthcare/life sciences sector and serves consumers around the globe.

The company operates through the clinical development and device segments. The former segment uses autologous stem cell-based therapeutics while the latter segment is involved in developing and commercializing automated technologies for bioprocessing and cell-based therapeutics.

The enterprise manufactures and markets an automated cryogenic storage and liquid nitrogen controlled-rate-freezing system dubbed the BioArchive Automated Cryopreservation system, which has been designed for cord blood samples and cell therapeutics with clinical applications; and an automated cell separation system known as the AXP II Automated Cell separation system, which isolates and retrieves stem and progenitor cells from blood in the umbilical cord. It also provides a sterile automated system dubbed the PXP point-of-care system, which has been designed to process autologous bone marrow aspirate extracted from stem cells at point-of-care, like in clinics or surgical centers.

The company is focused on pivoting from a device-only firm into a firm that provides the industry with cell-based contract development and manufacturing services. This is in addition to expanding its line of automated cell processing tools.

ThermoGenesis Holdings (THMO), closed Wednesday’s trading session at $1.21, off by 6.9231%, on 405,858 volume with 1,058 trades. The average volume for the last 3 months is 405,858 and the stock's 52-week low/high is $1.17/$4.45.

Tauriga Sciences (TAUG)

PennyStocks24, QualityStocks, Stock Analyzer, Market Intelligence Center Alert, Wallstreetlivechat, Greenbackers, Information Solutions Group, Penny Picks, Your Stock Alert, Premier Equity Reports, Jet-Life Penny Stocks, Stock Edge, Investor News Source, TradeThesePicks, Xtremepicks, Fast Moving Stocks, Damn Good Penny Picks, The Stock Brainiac, FreeRealTime, AskSlapper, BeatPennyStocks, OurHotStockPicks, OTCMagic, Bird Gang Stocks, HotOTC, Laissez Faire Today, Buzz Stocks, Penny Stock Bets, FeedBlitz, MajorPennyStocks, Stock Tips Network, Winston Small Cap, Wealth Insider Alert, Value Penny Stocks, TheMicrocapNews, StreetAuthority Daily, StockRockandRoll, StockOnion, StockLockandLoad,,, Penny Stock Rumble, Stock Market Media Group, smartOTC, Shiznit Stocks, PSNO.ORG, PoliticsAndMyPortfolio, PennyStocks Forever, AllPennyStocks, PennyPickAlerts, PennyDoctor and Stockgoodies reported earlier on Tauriga Sciences (TAUG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tauriga Sciences Inc. (OTCQB: TAUG) is a life sciences firm that is focused on the development, distribution, licensing and sale of proprietary products, which include cannabidiol infused chewing gum.

The firm has its headquarters in Wappinger’s Falls, New York and was incorporated in 2001, on April 8th. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm serves consumers in the United States.

The company is focused on the generation of profitable revenues in the natural wellness sector and the development of a proprietary synthetic biology platform technology, via Pilus Energy, its subsidiary. Its business strategy is to create a balanced and attractive portfolio of life sciences, without standard clinical regulatory timelines.

The enterprise operates through the Pharma and Tauri-gum segments. The former segment is focused on research and development of its FDA IND application for a phase 2 trial of its pharmaceutical grade version of Tauri-gum. On the other hand, the latter segment comprises of e-commerce, wholesale and retail product sales of its cannabidiol/cannabigerol products, which include Tauri-gummies and Tauri-gum. Its CBD-infused Tauri-gummies are Vegan formulated, Halal certified and Kosher certified and comes in many flavors, including pomegranate, blood orange and mint, while its CBD-infused Tauri-gum comes in the black currant and peach-lemon flavors. The enterprise also engages in equity investments and in evaluation of possible acquisition opportunities.

The firm is focused on building a world-class brand and creating lasting shareholder value. Currently, it continues to accelerate and strengthen its growth, which will be good for investments into the firm.

Tauriga Sciences (TAUG), closed Wednesday’s trading session at $0.051, up 2%, on 1,160,072 volume with 104 trades. The average volume for the last 3 months is 1.16M and the stock's 52-week low/high is $0.0235/$0.1985.

Outlook Therapeutics (OTLK)

QualityStocks, MarketBeat, StockMarketWatch, INO Market Report, BUYINS.NET, TopPennyStockMovers, The Online Investor, StreetInsider, Small Cap Firm, PoliticsAndMyPortfolio, MarketClub Analysis and InvestorPlace reported earlier on Outlook Therapeutics (OTLK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Outlook Therapeutics Inc. (NASDAQ: OTLK) (FRA: 41ON) is a late clinical-stage biopharmaceutical firm that is engaged in the development and commercialization of monoclonal antibodies for different ophthalmic indications.

The firm has its headquarters in Iselin, New Jersey and was incorporated in 2010, on January 5th by Pankaj Mohan. Prior to its name change in November 2018, the firm was known as Oncobiologics Inc. It serves consumers in the United States.

The company uses its Biosymphony biosimilars business models to achieve technical excellence and accelerated development, to help create affordable medications for patients around the globe. It is party to collaboration and license agreements with Zhejiang Huahai Pharmaceuticals Co. Ltd, BioLexis Pte. Ltd., Laboratorios Liomont S.A. de C.V., and IPCA Laboratories Ltd.

The enterprise is advancing a pipeline of 11 biosimilar products. Its product pipeline comprises of an ophthalmic formulation of bevacizumab dubbed ONS-5010, which will be administered as an intravitreal injection. The formulation is undergoing a phase 3 clinical trial evaluating its effectiveness in treating retina ailments like wet age related macular degeneration. Bevacizumab is a humanized, full-length anti-vascular endothelial growth factor (VEGF) recombinant monoclonal antibody which inhibits VEGF and related angiogenic activity. Its ONS-5010

The firm is focused on creating shareholder value and building momentum that will help bring the first ophthalmic bevacizumab formulation to be approved by the FDA to the retina space. Having released promising results from its latest pivotal study, the firm is continuing its shift towards commercialization.

Outlook Therapeutics (OTLK), closed Wednesday’s trading session at $1.29, off by 14.5695%, on 2,025,129 volume with 5,855 trades. The average volume for the last 3 months is 2.025M and the stock's 52-week low/high is $0.9285/$4.26.

LexinFintech Holdings (LX)

Kiplinger Today, MarketBeat, StreetInsider, Trades Of The Day, BUYINS.NET, StockMarketWatch, Daily Trade Alert, InvestorPlace, Schaeffer's, Zacks, Top Pros' Top Picks, Trading Concepts, MarketClub Analysis, The Street, InvestorsObserver Team, Wealth Insider Alert and StocksEarning reported earlier on LexinFintech Holdings (LX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LexinFintech Holdings Ltd (NASDAQ: LX) (FRA: 1LFA) is a holding firm which is engaged in the provision of online consumer financial services.

The firm has its headquarters in Shenzhen, the People’s Republic of China and was incorporated in 2013, on November 22nd by Qian Qiao and Wen Jie Xiao. Prior to its name change in March 2017, the firm was known as Staging Finance Holding Ltd. The firm has eight companies in its corporate family and serves consumers in China.

The company integrates Fenqile, its e-commerce-driven installment finance platform, with its online investment platforms, dubbed Dingsheng and JuziLicai, and advanced risk management technologies, to create a comprehensive consumer finance ecosystem.

The enterprise operates a membership platform known as Le Card, which provides benefits, savings and membership privileges to the leisure, hospitality, apparel, beverage and food sectors; and a consumption and consumer finance platform known as, which offers online direct sales with installment payment terms, as well as providing personal installment loans, installment purchase loans and other loan products. It also uses technologies like artificial intelligence, cloud computing and big data to allow the instant matching of user funding requests with offers from its many funding partners on the JuziLicai online investment platform. These partners include consumer finance companies, 3rd party commercial banks and other licensed financial institutions.

The firm recently announced its latest financial results for 2021, which show increases in its net profits. It is currently focused on expanding financing services for micro and small business owners, which may help extend its reach and bring in more investments.

LexinFintech Holdings (LX), closed Wednesday’s trading session at $4.01, off by 4.5238%, on 2,476,504 volume with 15,690 trades. The average volume for the last 3 months is 2.477M and the stock's 52-week low/high is $4.01/$15.42.


QualityStocks,, StocksToBuyNow, NetworkNewsWire, UndiscoveredEquities, MarketBeat, SeriousTraders, PennyStocks24, Xtremepicks, OurHotStockPicks, Pumps and Dumps, VIP STOCK ALERTS, SeeThruEquity Research, Standout Stocks, equities Canada, PennyStockLocks, Penny Stock 101, Penny Performers, OtcWizard, OTCPicks and StockRockandRoll reported earlier on GTX Corp (GTXO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GTX Corp. (OTC: GTXO) is a technology firm that is focused on designing, developing, manufacturing and selling complementary and interrelated services and products in the personal location and wearable technology services marketplace.

The firm has its headquarters in Los Angeles, California and was incorporated in 2002 by Louis Martin Rosenbaum and Patrick E. Bertagna. It operates as part of the communications equipment manufacturing industry and serves consumers around the globe, with a focus on the United States.

The company provides complete end-to-end solutions of connectivity, apps, middleware, hardware and professional services which can monitor and track assets or people. It generates revenues via the sale of products, professional services, recurring subscriptions and licensing. The company is party to a collaboration agreement with TulsaLabs.

The enterprise’s products include a near field communications tag and middleware app dubbed VeriTap, which monitors assets and logistics in the supply chain; and a wearable orthotic insole GPS monitoring, tracking and recovery solution for individuals who are at risk of wandering because of autism, dementia and Alzheimer’s disease, dubbed the GPS SmartSole. It is also involved in the development of a suite of mobile tracking applications known as the LOCiMOBILE, which turns tablets, smartphones and other GPS-enabled handsets into a real-time location-based tracking device. In addition to this,the enterprise provides Track my Work Force, which enables employers to monitor sales representatives, drivers and employees using tablets, smartphones and other wireless devices. The firm serves the military, enterprise and consumer markets.

The firm is focused on its long term growth strategy, which involves the launch of new products and entering into new collaboration agreements that will expand its product lines.

GTX Corp (GTXO), closed Wednesday’s trading session at $0.0127, off by 1.5504%, on 1,218,388 volume with 46 trades. The average volume for the last 3 months is 1.218M and the stock's 52-week low/high is $0.0061/$0.15.

Rivian Automotive Inc. (RIVN)

Kiplinger Today, The Street, Schaeffer's and InvestorPlace reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Engineers working at Purdue University say they have come up with a game-changing technology that could revolutionize electric vehicle (“EV”) charging. Presently, EVs take longer to charge compared to refueling a conventional gas-powered car. Tesla Superchargers are currently the fastest EV chargers on the market, and they take around 30 minutes to an hour to charge a battery to 80%. With funding from Ford, engineers have invented a new charging cable that could speed up charging time to only five minutes. If this technology reaches mass production, it could make EV charging as quick and efficient as fueling a gas car.

However, this new cable is still in the early developmental stages. The patent for the charging cable is still pending, and the researchers haven’t tested the technology with an electric vehicle yet. On top of that, these new cables will only work in conjunction with charging stations that can deliver plenty of power and EVs that have been designed to take more power.

Even so, the technology represents a significant step towards making electric vehicles as convenient and easy to use as possible. With the U.S. looking to reduce its carbon emissions as part of global efforts to combat climate change, making electric vehicles more attractive to the public and boosting adoption would be a great first step.

The Purdue University engineers made their breakthrough by addressing an issue that has been a constant hindrance to significantly increasing charging speeds: overheating. Flowing currents generate heat, and the faster the currents flow, the hotter it gets. As such, EV charging systems, including the battery and cable, will continue to heat up as the charging speed increases.

However, too much heat will degrade the batteries, reducing their ability to hold a charge and reducing their overall range. The engineers overcame this hurdle by using a liquid to vapor cooling system that can remove 10 times more heat than liquid cooling.

Issam Mudawar, a professor of mechanical engineering at Purdue University, has been working on the cooling technology for more than 30 years. When the temperature reduces, the charging cable’s performance increases by a wide margin, thereby safely accommodating more than 2,400 amps. This is five times what the Tesla Superchargers deliver at 520 amps and more than two times the 1,000 amps that are needed to bring charging times for large EVs to below five minutes.

EV charging times are being reduced at a crucial time when many electric vehicle startups, including Rivian Automotive Inc. (NASDAQ: RIVN), look poised to command a big stake of the market with vehicle models that motorists could grap up quickly if the bottleneck of inadequate charging infrastructure is addressed.

Rivian Automotive Inc. (RIVN), closed Wednesday’s trading session at $115.69, off by 3.3985%, on 13,317,022 volume with 179,770 trades. The average volume for the last 3 months is 13.275M and the stock's 52-week low/high is $95.20/$179.4699.

DeepMarkit Corp. (MKTDF), QualityStocks, StocksToBuyNow, NetworkNewsWire and SeriousTraders reported earlier on DeepMarkit Corp. (MKTDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DeepMarkit (TSX.V: MKT) (OTC: MKTDF) recently announced its entry into a non-binding letter of intent (“LOI”) to acquire all of the issued and outstanding shares of First Carbon Corp. (“FCC”). The LOI sets forth the general terms and conditions of the acquisition, pursuant to which FCC shareholders will receive an aggregate of approximately 15,000,000 common shares of DeepMarkit (“common shares”), each issued at a deemed price of $0.50, for deemed consideration of approximately $7,500,000 (the “acquisition”). In addition, DeepMarkit announced a non-brokered private placement. Under the private placement, subject to acceptance by the TSX Venture Exchange, DeepMarkit intends to issue, pursuant to applicable exemptions from prospectus requirements of Canadian securities laws, up to 4,000,000 units, each at a price of $0.50, for gross proceeds of up to $2,000,000. Each unit comprises one common share and one common share purchase warrant (each, a “warrant’). Each warrant will entitle the holder to purchase one additional common share of DeepMarkit at an exercise price of $1.25 for a period of three years from the date of the issuance.

To view the full press release, visit

About DeepMarkit

DeepMarkit is a technology company focused on creating new tools and technologies to aid businesses in sales development and increasing profitability. For more information, visit the company’s website at

DeepMarkit Corp. (MKTDF), closed Wednesday’s trading session at $0.238, even for the day. The average volume for the last 3 months is 500 and the stock's 52-week low/high is $0.106/$0.48.

HP Inc. (HPQ)

FreeRealTime, The Street, MarketClub Analysis, InvestorPlace, StreetInsider, StreetAuthority Daily, Kiplinger Today, Schaeffer's, SmarTrend Newsletters, StocksEarning, TopStockAnalysts, Barchart, MarketBeat, Money Morning, Zacks, internetnews, Street Insider, PROFIT CONFIDENTIAL, Louis Navellier, Uncommon Wisdom, InvestorGuide, Investopedia, Daily Markets, Daily Trade Alert, ProfitableTrading, MarketWatch, The Motley Fool, Market Intelligence Center Alert, Trades Of The Day, Dividend Opportunities, internet, Investor Guide, Daily Wealth, Money and Markets, Wyatt Investment Research, Trading Markets, WStreet Market Commentary, SiliconValley,, Stockhouse, The Wealth Report, SmallCapVoice, FNNO Newsletters, TradingMarkets, TheStockAdvisor, StreetAlerts, Super Stock Investor, CNBC Breaking News, Market Authority, Trading Concepts, Investors Alley, CustomerService, InvestorIntel, The Growth Stock Wire, The Online Investor, DrStockPick, Daily Dividends, StockEarnings, CRWEWallStreet, Wall Street Greek, PennyOmega, Market Wrap Daily, BestOtc, Insider Wealth Alert, Wealth Insider Alert, FeedBlitz, Dynamic Wealth Report, Investment House, Coattail Investor, Investment Contrarians, Market Report, Cabot Wealth, ChartAdvisor, The Street Report, StockHotTips, Wealth Daily, Investing Daily, Market FN, CRWEPicks, AllPennyStocks and The Best Newsletters reported earlier on HP Inc. (HPQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

HP Inc. (NYSE:HPQ) traded at a new 52-week high today of $37.52. This new high was reached on approximately average trading volume as 7.4 million shares traded hands, while the average 30-day volume is approximately 9.8 million shares.

HP Inc. is a leading provider of computers, printers, and printer supplies. The company's three operating business segments are its personal systems, containing notebooks, desktops, and workstations; and its printing segment which contains supplies, consumer hardware, and commercial hardware; and corporate investments. In 2015, Hewlett-Packard was separated into HP Inc. and Hewlett Packard Enterprise and the Palo Alto, California-based company sells on a global scale.

In the past 52 weeks, shares of HP Inc. have traded between a low of $21.80 and a high of $37.52 and is now at $37.10, which is 70% above that low price.

HP Inc. (NYSE:HPQ) is currently priced 3.2% above its average consensus analyst price target of $35.90.

HP Inc. (HPQ), closed Wednesday’s trading session at $36.46, up 3.3447%, on 24,514,563 volume with 157,480 trades. The average volume for the last 3 months is 24.291M and the stock's 52-week low/high is $22.08/$38.38.

The QualityStocks Company Corner

Vivos Therapeutics Inc. (NASDAQ: VVOS)

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc. (NASDAQ: VVOS).

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. (NASDAQ: VVOS) is an emerging global leader in the treatment of mild-to-moderate obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to rid the world of mild-to-moderate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of mild-to-moderate sleep apnea often caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established contract manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are among the leading causes of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective treatment for the estimated hundreds of millions of people globally who suffer from mild-to-moderate OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that studies have shown to be associated with sleep-disordered breathing—including mild-to-moderate OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,200 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in the treatment of mild-to-moderate OSA since CPAP.

The Vivos System has been specifically designed to promote the proper growth and development of the hard and soft tissues surrounding and comprising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which together form and shape the upper airway. As these areas develop more fully using the Vivos System, a patient’s airway typically widens and expands, enabling them to breathe properly through their nose. With a more open and less obstructed airway, and easier nocturnal breathing, the symptoms of SDB tend to diminish over time, and patients often report they no longer suffer from the adverse effects of SDB or OSA.

Use of the Vivos System is variable and case dependent, but typically recommended to be worn daily for 12 to 16 hours starting in the early evening and continuing overnight. The total treatment time typically ranges from 12 to 24 months, with 18 months being the approximate mean treatment time.

Biomimetic Oral Appliance

Vivos Therapeutics believes that the Vivos System technology represents the first non-surgical, non-invasive and cost-effective treatment for people with mild-to-moderate OSA.

Combining technologies and protocols that can alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA.

The Vivos System treatment is typically less than $10,000 and is often reimbursable by medical insurance as an out-of-network benefit.

A potentially serious medical problem with an alternative treatment therapy available in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically enhanced using the proprietary Vivos® System devices and clinical protocols.


R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.

Vivos Therapeutics Inc. (NASDAQ: VVOS), closed Wednesday’s trading session at $2.56, up 0.392157%, on 93,916 volume with 454 trades. The average volume for the last 3 months is 93,916 and the stock's 52-week low/high is $2.49/$14.41.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

Friendable (OTC: FDBL), a mobile technology and marketing company, released Fan Pass in July 2020 as a platform for artists to share their work and fans to get a front-row seat to the action from the comfort of their home. Since then, the platform has grown considerably. “During the latter part of 2021, the company’s main focus has been to make the Fan Pass platform more visible and accessible. Now, the company is focusing on moving into 2022, offering artists and fans the best that music offers,” reads a recent article. “Artists who sign up with the Fan Pass platform have an opportunity to take advantage of the unique revenue structure available. Artists earn by selling tickets to private events, monthly content views and the merchandise they offer online. Friendable also sets up monthly contests for artists to take part in. The company also incorporates a streaming gear store and an Artist Pro Services offering. Fans who sign up for Fan Pass get exclusive backstage and VIP access to their favorite artists — including a look at their daily lives. Fans are also provided access to artist live streams, exclusive merchandise, the ability to discover new music and, overall, more ways to connect with their favorite artists.” To view the full article, visit

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Wednesday’s trading session at $0.00405, off by 7.9545%, on 4,517,038 volume with 50 trades. The average volume for the last 3 months is 4.517M and the stock's 52-week low/high is $0.0037/$0.0979.

Recent News Inc. (NASDAQ: LTRY)

The QualityStocks Daily Newsletter would like to spotlight Inc. (LTRY). (NASDAQ: LTRY, LTRYW), a leading technology company that is transforming how, where and when the lottery is played, has appointed marketing veteran Greg Potts as its new global vice president of affiliate success. With more than two decades of strategic marketing experience, Potts has developed growth strategies for numerous consumer brands through targeted marketing efforts using co-op funding mechanisms. In his new position with, he will oversee the company’s business-to-business (“B2B”) growth strategy as well as its new Global Affiliate Marketing Program, which aims to add master affiliates and sub-affiliates while providing them with tools to accelerate the sales of products. Potts comes from Vericast, where he was a senior sales executive specializing in co-op marketing, customer activation and integrated media campaigns. In the coming weeks, is planning to unveil targeted multi-media marketing campaigns, including social media advertising, search engine optimization and interactive display advertising. In the announcement, Potts noted that’s new Global Affiliate Marketing Program offers an opportunity for the company to significantly grow its B2B2C user base. “On behalf of the entire team, we’d like to welcome Greg,” said CEO and co-founder Tony DiMatteo in the press release. “We expect that his experience and track record of successfully implementing affiliate market programs will be significant assets as we execute our strategic plan to expand and grow our B2B2C segment. Combined with our targeted marketing campaigns in our B2C segment, we anticipate reaching a wider audience and accelerating growth in both segments in 2022 and beyond.” To view the full press release, visit Inc. (NASDAQ: LTRY) is a next generation platform where consumers can play the lottery online – in browser or via smartphone app. The platform offers users access to official lottery games sanctioned by their individual states and also provides lottery data to more than 400 digital publishers, including Google and Amazon Alexa. was founded in 2015, launching at the LAUNCH festival and soon turning into a leader in the industry. With headquarters in Austin, Texas, the company is dedicated to helping advance the lottery industry into the digital age and works closely with state regulatory bodies to achieve this goal.

The company recently entered into a definitive agreement for a business combination with special purpose acquisition company Trident Acquisitions Corp. (NASDAQ: TDAC) (“Trident”), which will result in becoming a publicly listed company. Once the transaction is complete, the combined company will be trademarked as, with its common stock to remain listed on Nasdaq under ticker symbol ‘LTRY’. Online Platform

The online platform works closely with state regulators, advancing the lottery into the digital age. With the online platform, the company offers enhanced regulatory capabilities by leveraging innovative blockchain technology and capturing the untapped market of digitally native players.

Players go online in a browser or through a mobile application to use the interface. The process includes:

  • Players Choose a Game: Players can play officially state sanctioned multi-state games and other games offered in the states in which they live. Players can also find winning numbers, jackpot totals, draw dates and more for hundreds of other lottery games around the world.
  • Players Pick Numbers: Players can play their lucky numbers or do a quick pick of randomized numbers in as simple as two taps. “Tap, Tap, Ticket!”
  • A Safe and Secure Way to Play: Purchases for up to 50 tickets can be made at one time through the online interface. handles everything after purchase, letting users know when they win.
  • Collect All Winnings: Consumers keep 100% of their winnings. All winnings stay in the balance for future ticket purchases, or a cashout can be requested. Company representatives contact winners who hit big jackpots, instructing them on the redemption process.

A Better Way to Play the Lottery has an innovative e-commerce platform that is using blockchain to maintain an accurate ledger. From 2016 to 2020, grew gross revenue at a CAGR of 363%, and it forecasts gross revenue equal to approximately $71 million in 2021, $279 million in 2022, and $571 million in 2023. is leveraging a successful playbook, with $398 billion in global lottery sales but only 6.7% online penetration. The large market opportunity is expected to shift to online transactions within the next decade.

The platform is currently available in 12 states across the United States, and the company plans to expand to 34 by the end of 2023. Global expansion is also on the horizon, with partnership plans in Turkey and Ukraine.

Key features that make the experience unique include:

  • All the Games Users Love – For consumers who live in applicable LIVE states, Powerball and Mega Millions are available right from the mobile application.
  • Convenience – makes playing the lottery on mobile devices easy. After setting up an account, users can begin playing in moments or set reminders to play when the jackpot is high.
  • Easy Cashouts – Users can cash out winnings straight to a bank account, safely and securely, with no commissions.

The company is also gamifying charitable giving, fundamentally changing how nonprofits engage with donors and raise funds. is a platform designed to offer charitable donation sweepstakes to incentivize donors to take action by offering large cash prizes and once-in-a-lifetime experiences.

Strong Advisory Board Presence is expected to continue to gain support, leaning on the experience of its advisory board and notable investors from the venture capital, gaming and entertainment industries. These include:

  • Jason Robins, CEO of DraftKings Inc. (NASDAQ: DKNG)
  • Ben Narasin, Venture Partner of NEA
  • Peter Diamandis, Chairman of XPRIZE Foundation
  • Matthew Le Merle, Co-Founder and Managing Partner of Fifth Era and Keiretsu Capital
  • Paraag Marathe, President of Enterprises and EVP of Football Operations for the San Francisco 49ers
  • Jamie Gold, The Poker Philanthropist

Management Team

Tony DiMatteo is the Co-Founder and Chief Executive Officer of He is a serial entrepreneur and highly sought-after industry speaker and thought leader. He has been featured in The Wall Street Journal, Forbes, VentureBeat, TechCrunch Inc. and more for his approach to entrepreneurship, the gaming industry and cryptocurrency.

Matt Clemenson is the Co-Founder and Chief Commercial Officer of He is responsible for the company’s strategy. Mr. Clemenson was steeped in corporate and enterprise engineering processes at Hotwire and Expedia before going on to be CEO at LesConcierges, the world’s largest concierge company, which merged into John Paul and sold to Accor Hotels. Clemenson and DiMatteo have been partners for more than 10 years.

Ryan Dickinson is the company’s President and Chief Operating Officer. He has a diverse background in business, technology, product, design and sales, which has aided him in producing many successful outcomes throughout his career. Notably, as Senior Vice President of a SaaS company, Mr. Dickinson produced profitability from a negative $1.4 million division within the first year by reinventing the product offerings, streamlining processes and establishing a go-to-market strategy. Additionally, he produced three record breaking revenue years in a row for AccuWeather, the world’s largest weather provider, by increasing every KPI for all flagship properties by no less than 5%.

Luc Vanhal is the company’s Chief Financial Officer. He has served in C-level executive roles since the 1990s, including a nine-year tenure for The Walt Disney Company (NYSE: DIS) from 1990 to 1999. From 2001 to 2004, he managed the development of the World of Warcraft massively multiplayer game, which, by the end of 2020, still had over five million active subscribers. As the CFO of, Mr. Vanhal leads the company’s global finance organization, with treasury responsibility, accounting, analysis and financial planning. Inc. (LTRY), closed Wednesday’s trading session at $6.52, off by 2.1021%, on 1,056,615 volume with 5,246 trades. The average volume for the last 3 months is 1.057M and the stock's 52-week low/high is $6.22/$17.50.

Recent News

Cannabis Strategic Ventures Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures Inc. (NUGS).

  • MDRN (Modern) Tree is key piece of company’s vision to build a full farm-to-sale vertical model
  • NUGS plans to grow MDRN Tree brand, develop model that gives cultivation business wider distribution at potentially higher margins
  • The MDRN Tree location is opening in top cannabis market in the world

Cannabis Strategic Ventures (OTC: NUGS) has announced the grand opening of its first Los-Angeles-based, customer-facing MDRN (Modern) Tree cannabis dispensary ( The company started recording sales from the dispensary this month. Last month, NUGS took full operational control of the downtown Los Angeles MDRN Tree cannabis product dispensary, the company’s first in-house, end-market, consumer-facing retail sales outlet.

Cannabis Strategic Ventures Inc. (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator. The company is based in Los Angeles, with a 6-acre cannabis farm in Northern California called NUGS Farm North. The company’s vision is to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration.

Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the City of Los Angeles and the State of California, and it is now working toward taking operational control of each license. The company also recently announced the upcoming grand opening of its cannabis dispensary, MDRN Tree. Following that launch, Cannabis Strategic Ventures intends to deploy another of its new licenses to establish an indoor cultivation facility with capacity to produce two to three pounds of premium exotic cannabis flower per light per harvest. The facility will have up to 1,200 grow lights and is anticipated to yield 5.75 harvests per year, bringing it to a total production capacity of over 15,000 pounds of cannabis flower annually.

Brand Portfolio

The company owns multiple brands under the Cannabis Strategic Ventures umbrella. The firm’s NUGS brand provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands.

The NUGS Farm North brand operates as a six-and-a-half-acre cannabis cultivation property located in northern California. The company believes that the key to success in its business is consistent quality and reliable supply to fit growing consumer demand. Cannabis Strategic Ventures addressed these consumer needs by building NUGS Farm North. At NUGS Farm North, the company’s process is customized, and its product is consistent. Located in the heart of an agricultural mecca for globally distributed produce, NUGS Farm North finds power in its product, not in its size. Decades of agricultural experience and a dedication to consistency ensure quality cannabis.

MDRN Tree is Cannabis Strategic Ventures’ customer-facing dispensary brand. MDRN Tree will open its first Los Angeles location sometime in the fall of 2021. MDRN Tree will be the company’s factory retail store – a direct interface with the end-market community – where Cannabis Strategic Ventures plans on showcasing the cannabis flower produced at its NUGS Farm North cultivation site. This farm-to-sale model offers the potential to drive simultaneous gains in quality control and profitability.

Market Outlook

The demand for legal marijuana is expected to surge due to ongoing changes in U.S. state government policies toward cannabis. In addition, the number of indications for which medical marijuana is prescribed continues to increase steadily. These factors are expected to rapidly boost legal sales of cannabis products, opening new revenue channels for producers and retailers. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will only present more high growth opportunities for this market.

According to a report from Grand View Research, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a compound annual growth rate of 26.7 percent from 2021 to 2028. That CAGR would put the market value at roughly $30 billion as soon as 2025.

According to the report, “One of the major factors fueling market growth is the expanding demand for legal marijuana owing to the growing number of legal cannabis countries. (Due) to recent legalizations in different countries, the use of medical marijuana for various ailments is gaining momentum worldwide. Patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s, and many neurological disorders are administered medical marijuana. The demand for cannabis oil is increasing rapidly, especially among countries with legalized medical marijuana.”

Management Team

Simon Yu is CEO, President, CFO and Secretary of Cannabis Strategic Ventures. He is also a co-founder, former COO and board member of Clubhouse Media Group Inc., a publicly traded social media company. Mr. Yu holds an MBA from the University of Southern California.

Cannabis Strategic Ventures Inc. (NUGS), closed Wednesday’s trading session at $0.03, up 5.2632%, on 1,065,800 volume with 72 trades. The average volume for the last 3 months is 1.066M and the stock's 52-week low/high is $0.0261/$0.62.

Recent News

InnerScope Hearing Technologies Inc. (OTC: INND)

The QualityStocks Daily Newsletter would like to spotlight InnerScope Hearing Technologies Inc. (INND).

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, is partnering with Giant Eagle Inc. to install INND hearing kiosks in supermarkets located throughout Pennsylvania and Ohio. A grocery and pharmacy chain, Giant Eagle is one of the country’s largest retailers. The agreement calls for InnerScope to deploy its proprietary hearing kiosks in six locations initially, with more planned; Giant Eagle has more than 470 locations in Pennsylvania, Ohio, West Virginia, Maryland and Indiana. The kiosks allow Giant Eagle customers to easily and quickly self-check their hearing and obtain instant results. Customers can also receive vital information about hearing loss as well as suggestions for solutions, including InnerScope's hearing-aid solutions. “InnerScope is thrilled to have the opportunity to bring affordable hearing solutions to millions of Americans through Giant Eagle's incredible and expansive network of over 470 neighborhood grocery and pharmacy stores,” said InnerScope president and CEO Matthew Moore in the press release. “Partnering with Giant Eagle, one of the nation's largest retailers, is a tremendous opportunity for InnerScope to broaden its reach to help more of the 48 million Americans who currently suffer from hearing loss to access more affordable choices of hearing aids to treat their hearing loss. We believe having convenient access to free self-check hearing screenings with InnerScope's hearing kiosks and its affordable hearing aids will lead the tens of millions of Americans to treat their hearing loss sooner rather than later by purchasing hearing aids, preferably one of InnerScope's hearing products. Moreover, we are excited to work with Giant Eagle's management to expand on their new hearing health category for in-store and online sales.” To view the full press release, visit

InnerScope Hearing Technologies Inc. (OTC: INND) is a Nevada corporation incorporated on June 15, 2012, with its principal place of business in Roseville, California. The company was initially started in 2006 – operating as InnerScope Advertising Agency Inc. – to provide advertising and marketing services to retail establishments in the hearing device industry. On August 25, 2017, the company changed its name to InnerScope Hearing Technologies Inc. to better reflect its current direction as a hearing health technology company that manufactures, develops, distributes and sells numerous innovative hearing health-related products, hearing treatments and hearing solutions, direct-to-consumer (DTC) through a scalable business model.

The company is a manufacturer and a distributor/retailer of DTC, FDA (U.S. Food and Drug Administration) registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (PSAPs), hearing-related treatment therapies, doctor-formulated dietary hearing supplements, proprietary CDB oil for treating tinnitus and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems. The company’s mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.

The management team of InnerScope is applying decades of industry experience and believes it is well-positioned, with its innovative in-store point-of-sale Free Self-Check Hearing Screening Kiosks (“Hearing Kiosks”), to directly benefit when the Over the Counter (OTC) Hearing Aid Act (the “OTC Hearing Aid Law”) is enacted (expected in late 2021 based on the President’s Executive Order issued on July 9, 2021) The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without having to see a professional. InnerScope’s Hearing Kiosk is designed to help the tens of millions of Americans with undetected/untreated mild-to-moderate hearing loss treat themselves with the company’s easy, convenient and affordable OTC hearing aids, in-store and/or online.

Industry Game-Changer – New Emerging Market with 48 Million Potential Customers

The following is sourced from The White House Fact Sheet detailing an Executive Order from President Biden aimed at saving Americans with hearing loss thousands of dollars by allowing hearing aids to be sold over the counter at drug stores:

“Hearing Aids: Hearing aids are so expensive that only 14% of the approximately 48 million Americans with hearing loss use them. On average, they cost more than $5,000 per pair, and those costs are often not covered by health insurance. A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary. Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market.”

On July 9, 2021, President Biden noted the following in reference to his Executive Order relating to hearing aids:

“Right now, if you need a hearing aid, you can’t just walk into a pharmacy and pick one up over the counter. You have to get it from a doctor or a specialist. Not only does that make getting hearing aids inconvenient, it makes them considerably more expensive, and it makes it harder for new companies to compete, innovate and sell hearing aids at lower prices.”

“As a result, a pair of hearing aids can cost thousands of dollars. That’s a big reason why just one in seven Americans with hearing loss actually use a hearing aid.”

InnerScope Game-Changers

For InnerScope, this Executive Order could present a significant opportunity. The company is uniquely positioned with a number of strategic advantages and offerings in the space, including:

  • First to Market: Free self-check hearing screening kiosks deployed in national pharmacy chains, big-box retailers & national and local groceries chains
  • Online Hearing Screening Tests: For national retailers to use their websites to attract more customers in conjunction with the company’s in-store hearing kiosks
  • The HearIQ App for iOS and Android users: Offers a free self-check hearing test and provides a user control function for InnerScope’s Bluetooth app-controlled self-adjusting rechargeable hearing devices
  • Customer Monthly Subscription Model: Offering the lowest, most affordable monthly payment options (as low as $42 per month for pair of rechargeable, app-controlled hearing aids) for consumers to purchase hearing aids and receive free upgrades every two years.

The In-Store Hearing Screening Kiosks and Online Free Hearing Screening Tests

Innerscope’s hearing screening kiosk and online hearing screening tests offer free self-check hearing evaluation using the world’s first “Hearing Triage” artificial intelligent pattern recognition software, which has a unique ability to classify both level (degree of loss) and pattern (type of loss). In addition, the software can detect the probable location of the hearing problem and its degree of severity.

The tests are developed as a hearing wellness tool to help track hearing ability and (if tests results indicate a hearing loss) make recommendations for in-store point of sale or online purchase of one of InnerScope’s hearing devices, as well as providing recommendations to see one of the professionals in InnerScope’s local contracted network of hearing health care experts for further follow-up testing if necessary. The software also generates an audiometric report which is instantly emailed to the customer.

The HearIQ App

InnerScope is the creator of the HearIQ App, which offers free self-check hearing tests and provides a user control function for InnerScope’s line of Bluetooth app-controlled self-adjusting rechargeable hearing devices. InnerScope developed the free hearing test part of the HearIQ App to help with the early detection of hearing loss for the 1.5 billion people worldwide who have untreated hearing loss or some form of hearing issues that may be undetected and do not have access to a computer for InnerScope’s online hearing screening test.

Hearing Aid Products

Through its dedicated online store,, InnerScope offers affordable, direct-to-consumer, Bluetooth app-controlled, self-adjusting hearing technology to empower consumers to take control of their hearing care. InnerScope’s hearing technology allows the customer in less than 10 minutes using any smartphone to personalize each hearing device to their hearing needs using an onboard in-ear custom-fit self-testing feature through the HearIQ App.

InnerScope is shifting hearing health care from traditional brick-and-mortar hearing care clinics to customers’ homes by providing a unique solution to give customers top quality, affordable access to hearing aids without the need to see a hearing professional or go to a hearing care clinic. As a result, InnerScope can deliver the same level and quality of hearing technology and expert support for the customer from their homes at a fraction of the cost of traditional channels. All InnerScope hearing aid devices are medical-grade and available with professional remote programming and support services from one of the company’s licensed hearing professionals through the HearIQ App.

Hearing & Tinnitus Dietary Supplements

InnerScope has developed a proprietary line of doctor-designed hearing & tinnitus dietary supplements to help people with hearing problems protect themselves from future hearing issues. There are currently three types of formulas to choose from, including Ear-Ring Relief for the 60 million Americans who suffer from tinnitus, HearingVite + Memory Boost for people with hearing loss and cognitive issues, and HearingVite + Multivitamin for maintaining proper hearing health and levels of nutrients.

Complete Line of Hearing Health Care Products

InnerScope offers a brand label of assorted ear care and hearing aid maintenance products. In support of overall ear health and ensuring maximum performance from its hearing aids and comfort for its customers, InnerScope provides a whole line of care items, including cleaning kits, wipes, spray and drying tablets, ear cleaner for wax removal, a natural lubricant agent for new hearing aids and hydrating lubricating ear gel.

Verified Wholesale and Direct-to-Consumer Sales

InnerScope is a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing aids, personal sound amplification and hearing health accessories. InnerScope also created an easy shopping experience for its hearing and tinnitus vitamins through Walmart and Amazon Prime. With new partnerships in the works, the company aims to add other online and brick-and-mortar establishments to its vitamin distribution network in the future.

Hearing Aid Market Outlook

The global hearing aid market is expected to reach $11.02 billion by 2028, growing at a CAGR of 7.4% during the forecast period. This marks a significant increase from the $6.47 billion value reported in 2020, an increase largely driven by innovations being made in hearing aid technology (

As a leading wholesale provider and direct-to-consumer business, InnerScope is positioned to disrupt the global hearing aid market. Its partnerships with some of the United States’ largest retail distributors and wholesalers are only strengthening the company’s position within the industry.

Management Team

Matthew Moore is the President and CEO of InnerScope Hearing Technologies Inc. He grew up in the hearing health industry, working alongside his grandfather through internships and mentorships. At the age of 10 years old, he became Chief Marketing Officer and Chief Operating Officer of his parent’s private hearing aid practice, the largest in Northern California and the second largest in the state. Matthew has shown his leadership ability by creating distribution partnerships with big industry names and independent retailers/pharmacies.

Kim Moore is the Chief Financial Officer of InnerScope Hearing Technologies Inc. She has worked in the hearing aid industry for over 45 years, helping her father maintain his hearing aid practice in Central Valley, California. She began working on marketing with her father at the age of eight, learning that no customer walks through the door without proper advertising and marketing. As a licensed hearing instrument specialist, Kim has given hearing tests to more than 30,000 people.

Mark Moore is the Chairman and Co-Founder of InnerScope Hearing Technologies Inc. He has over 35 years of experience in hearing aid dispensing, practice management, private label brand management and hearing aid marketing. He has personally fit hearing aids to over 10,000 hearing-impaired people. In addition, he has been responsible for developing and testing proven new industry marketing and advertising methods and best practice strategies, which has made him one of the most sought-after experts in the hearing aid industry. Mark was previously a columnist for Advanced for Audiologists, a global industry publication, and served on the American Academy of Audiology (AAA) advisory board for AudiologyNow conventions. He has also developed patented and patent-pending nutritional supplements for hearing-related issues, aural rehabilitation programs and low-level laser therapy for tinnitus and sensorineural hearing loss.

InnerScope Hearing Technologies Inc. (INND), closed Wednesday’s trading session at $0.0148, off by 0.3367%, on 42,919,817 volume with 868 trades. The average volume for the last 3 months is 42.81M and the stock's 52-week low/high is $0.0001/$0.098.

Recent News

RYAH Group Inc. (CSE: RYAH)

The QualityStocks Daily Newsletter would like to spotlight RYAH Group Inc. (CSE: RYAH).

Last week, Rep. Nancy Mace, who introduced a measure to federally legalize cannabis, revealed that she had used the herb in her youth as a substitute for her depression medication after she was raped. The Republican Congresswoman revealed in an interview on Fox Business that she was raped when she was 16, explaining that the prescribed medications to deal with depression which she’d been given only made her feel worse, which is why she turned to marijuana for help. Mace asserted that she understood the need to offer access to vulnerable communities, such as military veterans who suffer from various mental health issues including PTSD, because she had experienced the therapeutic benefits of marijuana firsthand. The congresswoman stated that the new bill was especially protective of veterans because it ensured that they weren’t discriminated against and would allow them to use marijuana to manage their post-traumatic stress disorder symptoms. The admission by the Congresswoman that cannabis helped her deal with her mental issues after she was raped shows the potential of marijuana to help treat various conditions. Researchers may be able to take advantage of various IoT dose-measuring devices, such as those made by RYAH Group Inc. (CSE: RYAH), as they investigate the best dosages that can trigger the therapeutic benefits of cannabis.

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Product Portfolio

The company’s current portfolio incorporates an ecosystem of IoT products, each consisting of three elements: the device, the medicine-carrying component and the mobile application. The product line currently includes a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage.

RYAH Smart-Inhaler

The RYAH Inhaler is the first dry-herb inhaler that allows users to track and control how much is inhaled, providing consistent and predictable results. This inhaler connects with the RYAH Health App, which features stat-tracking and presets for temperatures and dosages, all of which can be customized to individual needs and doctor recommendations, as well as a post-session review mechanism that allows the collection of session data and feedback for further efficacy analysis for customized dosing capabilities.

RYAH’s proprietary stainless-steel cartridges for the inhaler use QR technology that contains lab testing and grower information pertaining to the specific strain, thereby mitigating elicit product use and enabling completely transparent remote medicinal analytics, from seed to consumption.

In addition, the RYAH Cartridges provide a unique closed-loop recurring revenue opportunity for the company, as the RYAH Inhaler only works with this type of proprietary cartridges that licensed partners fill with medicine. The partners benefit from all the back-end data, providing them access to consumption habits, statistics and other data on patient preferences.

RYAH Smart-Patch

The RYAH Smart Transdermal Patch is a lightweight, reusable, mobile-controlled patch used for site-specific therapies. The Patch is an Electronic Topical Delivery Patch system intended for recommendation and administration by pain relief professionals and physical and occupational therapists. The patch data and the heating element is completely IoT and controlled by RYAH’s proprietary smartphone applications, which allows scheduling and ‘boosting’ medicine release, on-demand.

RYAH Smart-Pen

The RYAH Pen is an app-controlled liquid dispenser designed to provide a precise mix of up to three medicine components to create an ‘entourage effect’, enabling customized, wide-spectrum recommendation opportunities by licensed clinicians. The Smart-Pen will feature cartridges that contain CBD, THC and other isolates such as flavonoids or vitamins, or other solutions. There is a built-in mechanism designed to control usage based on recommended dosing schedules.


RYAH MD serves as a remote and interactive patient-doctor collaboration and dosing administration platform. Doctors can remotely set dosage amounts for their patients, creating digital prescriptions for the RYAH IoT devices and tracking patient usage in real-time. RYAH MD offers features that include real-time monitoring, appointment booking, doctor-patient video calls and science-based strain recommendations, as well as promoting a better understanding of the effects and benefits of those recommendations among patients. Information is gathered from all of the RYAH devices.

PotBot App

The PotBot App is a medical cannabis education mobile application that leverages patented AI technology to capture structured and unstructured data to assist patients in learning about various treatments in plant-medicine based on their efficacy goals. The PotBot App is currently one of the top-rated medical cannabis educational mobile applications on the Apple App Store in the United States, with over 300,000 downloads.

Through the combination of peer-reviewed and empirical data, the PotBot App provides detailed information on the targeted and tested cannabinoid levels and associated strains from cannabis patients. The result is personalized and driven by data to inform patients of potential product matches associated with similar ailments and efficacy goals.

Market Outlook

RYAH holds a unique position in the $100.3 billion medical plant market, with the potential to capture and capitalize on growth opportunities made available by both the IoT and Data Intelligence sectors.

In 2018, the global IoT market was valued at $212.1 billion, and it is expected to grow exponentially to $1.3 trillion by 2026, registering a CAGR of 25.68%, according to Verified Market Research (

Management Team

Dr. Boris Goldstein, Ph.D., is the founder and Chairman of RYAH Group. He is a seasoned entrepreneur, investment banker and venture capitalist. He started his career as the founder of Software House HT, which grew into a worldwide corporation with over 40 offices in 17 countries. Since then, Goldstein has founded and served on the boards of directors and advisory boards for numerous companies in Silicon Valley and Silicon Alley. Goldstein brings experience in fundamental research, investment and technology, authoring multiple patents and books.

Gregory Wagner, MBA, is Chief Executive Officer and Director of RYAH Group. He has over 20 years of experience in global financial markets and entrepreneurship. Wagner has held executive roles in the United States and London. He has co-founded and built several startups from the ground up. His current licensures and degrees include FINRA Series 7, 63, 24 and 55, as well as an MBA from Fordham University. Wagner received a Certification in Innovation and Strategy from Harvard University.

RYAH Group Inc. (CSE: RYAH), closed Wednesday’s trading session at $0.055, up 10.00%, on 2.24M volume with 87 trades. The average volume for the last 3 months is 718,349 and the stock's 52-week low/high is $0.04/$0.20.

Recent News


The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has announced that, from this date forward, it will no longer have to consolidate the financials of BIGtoken (OTC: FPVD). On Sept. 27, 2021, BIGtoken, the leading platform for ethically-sourced identity, data and insights creation and media activation, and BritePool Inc., a leading identity verification company for advertisers and publishers, entered into an agreement and plan of merger in an all-stock transaction. Upon completion of the union, SRAX is no longer obligated to consolidate BIGtoken into its financials. SRAX currently holds the BIGtoken position on the balance sheet at approximately $4,000,000, which will now be adjusted on a quarterly basis to mark the position to market. “We incubated BIGtoken and provided the infrastructure for BIGtoken so they can be their own company,” said SRAX founder and CEO Christopher Miglino. “The management team is one of the best in the industry, and we look forward to them achieving the vision of consumers owning their own data.” To view the full press release, visit

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.


BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.


Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday’s trading session at $4.92, off by 6.2857%, on 204,473 volume with 1,871 trades. The average volume for the last 3 months is 204,473 and the stock's 52-week low/high is $2.37/$7.29.

Recent News

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

The QualityStocks Daily Newsletter would like to spotlight Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF).

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) recently submitted an Investigational New Drug (“IND”) application to the U.S. FDA to evaluate its TRP-8802 clinical candidate in a phase 2a clinical trial to explore psilocybin-assisted therapy’s safety and preliminary effectiveness among individuals dealing with fibromyalgia. The study, which is being conducted in collaboration with the University of Michigan, spearheaded by Kevin Boehnke, Ph.D., will involve 20 fibromyalgia patients and include various exploratory endpoints, particularly given the high prevalence of comorbidities that include anxiety, depression, poor sleep quality and other conditions. Tryp expects to initiate the study in 2022, subject to a favorable review of the IND by the FDA. “With this specific study, the company seeks to offer a more effective fibromyalgia solution than those that are currently available in the market today. It also aims to provide a long-lasting solution with fewer side effects, ultimately affording patients better treatment for their condition,” notes a recent article. Greg McKee, chairman and CEO of Tryp, comments: “We have been working diligently to complete this IND submission and are eager to initiate what will be one of the first evaluations of psilocybin to treat fibromyalgia in a phase 2 study.” To view the full article, visit Research on psychedelic substances has led to the discovery of the numerous benefits that these substances possess, which could be utilized in the treatment of various mental health conditions. A recent study has found that psychedelic substances can alter an individual’s beliefs on metaphysics. Metaphysics refers to a branch of philosophy that focuses on “being.” With the high rate at which research on psychedelic compounds is being done, it may not be long before several medicinal formulations from companies such as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) are approved by regulators and become available to the patients who need them.

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) is a pharmaceutical company focused on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathways.

The company was founded in 2019 and is headquartered in San Diego, California.

Innovative Drug Pipeline

Tryp’s current focus is on advancing its two drug development platforms: its Psilocybin-for-Neuropsychiatric Disorders (PFN™) program targeting fibromyalgia, eating disorders and chronic pain conditions; and razoxane for soft tissue sarcomas. The company intends to explore opportunities to monetize these platforms after generating Phase 2b clinical data.

The company’s development plans cover three strategic initiatives:

  • Develop: Tryp intends to utilize the FDA’s 505(b)(2) regulatory pathway with available third-party preclinical data to shorten the timelines and lower the cost of its development programs.
  • Protect: Tryp plans to utilize regulatory exclusivity, patents, trade secrets and proprietary know-how to protect the commercial lifespan of its drug candidates.
  • Monetize: Tryp intends to seek out licensing, acquisition and co-development opportunities for drug candidates following their Phase 2 stages of development.

PFN™ Program

Through its PFN™ program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that have distinct advantages over other drugs currently on the market or in development. These advantages include:

  • Increased efficacy
  • Natural blood-brain barrier penetration
  • Enhanced safety and toxicity profiles
  • Reduced risk of abuse
  • Reduced risk of addiction

Tryp’s PFN™ program features its lead drug candidate, TRP-8802. The company’s initial indication for TRP-8802 is fibromyalgia.

Fibromyalgia is believed to be a neurosensory disorder characterized in part by abnormalities in pain processing by the central nervous system. The three drugs with FDA approval for the treatment of fibromyalgia are Pregabalin (Lyrica®), Duloxetine (Cymbalta®) and Milnacipran (Savella®), which are only effective for a portion of patients suffering from the condition.

Tryp plans to seek FDA approval to proceed directly to Phase 2 clinical trials evaluating TRP-8802 as a treatment for fibromyalgia based on existing preclinical and clinical data for the active pharmaceutical ingredients in TRP-8802.

Tryp’s pipeline of indications for TRP-8802 also includes eating disorders and certain forms of chronic pain. The company expects to initiate Phase 2a clinical trials in these areas in 2021.

Tryp recently partnered with Albany Molecular Research Inc. (“AMRI”) for the manufacture of the company’s synthetic psilocybin using proprietary methods. AMRI has initiated the process of manufacturing a 200g non-GMP demonstration batch of psilocybin and will produce a batch of GMP psilocybin in mid-2021. As the holder of the Drug Master File, Tryp expects to be the only U.S.-based manufacturer of synthetic psilocybin in the industry.


Tryp’s second drug candidate, TRP-1001 (razoxane), is being developed as a treatment for soft tissue sarcomas and has been evaluated in multiple Phase 2 clinical trials conducted by clinicians unaffiliated with Tryp. The company believes that existing clinical data regarding razoxane will likely allow TRP-1001 to be studied in a Phase 2 trial without the need for extensive preclinical or Phase 1 trials.

Sarcomas are rare tumors that are derived from connective tissues in the body and comprise 7% of all cancers in children. In 2018, an estimated 13,000 new cases of soft tissue sarcoma were diagnosed, with the tumors resulting in over 5,000 deaths during that year in the United States alone (

Market Outlook

With its drug development programs targeting multiple indications, Tryp is well positioned to capitalize on growth opportunities spanning a range of therapeutic markets. The global oncology drugs market, in particular, represents a sizable opportunity.

In 2018, oncology indications accounted for 25% of all drug sales, representing approximately $151 billion in market revenues. By 2024, spending on oncology-targeted therapeutics is expected to top $200 billion and account for roughly 30% of total drug sales, according to a study by Cowen Equity Research (

Valued at $764 million in 2020, the global fibromyalgia treatment market presents unique opportunities for development due to the limited number of approved therapies. With treatment trending upward, the market is expected to grow at a CAGR of 9.2% and reach $1.4 billion in value by 2027 (

Management Team

Greg McKee is the Chairman and CEO of Tryp Therapeutics. He has more than 20 years of life sciences management and venture investment experience that he brings to the company. Before taking his role at Tryp, he was the founder of Torrent Ventures, an early-stage digital health and medical technology venture fund. Mr. McKee also served as the CEO of CONNECT, the largest Southern California start-up accelerator. Before this, he was the chairman, president and CEO of then publicly traded Nventa Biopharmaceuticals, which successfully merged with Akela Pharma. Mr. McKee earned a B.A. in Economics from the University of Washington, an M.A. in International Studies from The Joseph H. Lauder Institute, and an MBA from the Wharton School at the University of Pennsylvania. He has been a member of the Young President’s Organization (YPO) since 2006.

James Gilligan, Ph.D., is the company’s President and Chief Science Officer. He has over 35 years of experience in the life sciences industry, including research and development, clinical development, international regulatory affairs and manufacturing. Before joining Tryp, Dr. Gilligan was the Co-Founder and Managing Partner of The Bracken Group, a life sciences consulting firm. He was also the Co-Founder of Unigene Laboratories, which develops technology for the recombinant manufacture of peptide hormones. Dr. Gilligan received his Ph.D. in Pharmacology from the University of Connecticut and a MSIB from Seton Hall University. He continued his post-graduate education at the Roche Institute of Molecular Biology.

Tom D’Orazio is the Chief Operating Officer of Tryp Therapeutics. He has extensive experience in leading the development and commercialization of vaccines, drugs, radiopharmaceuticals and biologics. His prior leadership experience has been in commercial planning, marketing, partnership and business development roles. He was formerly the CEO of ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), where he led the transition from a private company to a public one. He co-founded and served as CEO of Superna Life Sciences, a specialty-pharma company focusing on niche drugs for cancer patients in Canada. Mr. D’Orazio has an MBA from Vanderbilt University with a primary focus in both finance and marketing and a B.Sc. in chemistry from Loyola University of Chicago.

Luke Hayes is the company’s Chief Financial Officer. He has played an active role in the life science industry for over 20 years with technology transfer, venture capital and finance experience. His career started with business development for Dow Chemical (NYSE: DOW), with responsibility for pharmaceutical customers such as Eli Lilly and AbbVie. Mr. Hayes has spent more than a decade doing venture capital investing while supporting companies as a director and advisor. He earned a B.S. in Chemical Engineering from Brigham Young University and an MBA from the UCLA Anderson School of Management.

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), closed Wednesday’s trading session at $0.2, off by 4.8072%, on 70,899 volume with 41 trades. The average volume for the last 3 months is 70,899 and the stock's 52-week low/high is $0.1999/$1.04.

Recent News

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF)

The QualityStocks Daily Newsletter would like to spotlight StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF).

StraightUp Resources (CSE: ST) (OTCQB: STUPF) today announced its receipt of confirmation from the Depository Trust Company (“DTC”) that its common shares are now eligible for electronic clearing and settlement through DTC in the United States. DTC eligibility reduces costs and accelerates the settlement process for investors and brokers, allowing the company's common shares to be traded over a much wider selection of brokerage firms by coming into compliance with their requirements. “DTC eligibility improves StraightUp’s access to the marketplace during our next phase of growth,” said StraightUp’s president and CEO Mark Brezer. “I expect our shareholders to benefit from the liquidity and ease at which shares can now be electronically transferred between U.S. brokerages, at a lower cost and greater efficiency.” To view the full press release, visit

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) is a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America. The company’s flagship properties are located in the Red Lake Mining District of Ontario, Canada, renowned for over 30 million ounces of historic gold production. Other key projects extend into the neighboring Meen-Dempster Greenstone Belt of the Uchi Subprovince. The company’s management team is led by dedicated professionals, aiming to maximize shareholder value while employing modern exploration techniques and principles to achieve its goals.

The mission of StraightUp Resources is to maximize shareholder wealth through mineral discoveries at projects with robust potential, maintain long-lasting partnerships, and continue to focus on the acquisition, development and exploration of mineral resource properties in North America. The company’s objective is to continue to locate and develop economic, precious and base metal properties of merit.

The company’s 10,000-hectare (almost 25,000 acres) RLX Projects are contiguous to various Evolution Mining, Great Bear Resources, Pacton Gold and Dixie Gold properties. Its 2,000-hectare (just under 5,000 acres) Belanger Project is contiguous to Infinite Ore’s Fredart and Garnet/Arrow properties. StraightUp intends to conduct exploration on the RLX North, RLX South, Belanger and Ferdinand Gold properties located in the Red Lake District, a location touted as having one of the best metal-endowed greenstone belts in the world. The Bear Head Gold Project is located within the Meen-Dempster Greenstone Belt of the Uchi Subprovince, approximately 80 kilometers west of the Pickle Lake Gold Camp and 14 km northeast of the former gold mine, Golden Patricia. It amassed 620,000 ounces of gold at an average of 15.2 g/t Au from 1988-1997. The property is bordered by an Australian miner massive gold project. Known gold occurrences are already mapped on the Bear Head property, as are previous drill holes and results. Once the data is re-examined, an exploration budget and subsequent plans will be announced by the company.


Ontario’s Red Lake Mining District is one of Canada’s most prolific gold mining districts, renowned for its high-grade gold deposits. This is a mining-friendly, politically stable jurisdiction with a skilled labor force and infrastructure specifically built around meeting the needs of the mining industry.

RLX North & South Projects
At over 10,000 hectares, the RLX North and RLX South Projects represent a district-scale exploration opportunity. The RLX North and RLX South Projects are well positioned on-strike to the southeast of the district’s largest gold deposit (Red Lake Gold Mines – Evolution Mining). The project is adjacent to Great Bear Resources’ Sobel Project. Great Bear Resources is also in the process of evaluating the area for significant regional-scale structural controls and has proposed additional work on its neighboring project in the near term. These properties are highly accessible, with the southern boundary only eight kilometers from the paved highway into Red Lake, and can be accessed by forest service roads which traverse throughout the properties.

Belanger Project
Historic exploration work on the 2,000-hectare property has identified three significant surface exposures of gold, copper and silver. Early exploration work will focus on validating historic sampling results and following the occurrences along strike with a view to better understanding the nature and controls on mineralization. The property has excellent forest road access from the town of Ear Falls.

Ferdinand Gold Project
The Ferdinand property is situated within the southeastern extension of the Confederation-Uchi greenstone belt, one of the most metal-endowed greenstone belts in the world by square kilometer. It consists of 17 contiguous mining claims covering approximately 7,143 hectares (17,650 acres), located 13 kilometers northwest of the town of Slate Falls. Access is currently by logging roads, with forestry logging operations scheduled for expansion on the property. StraightUp recently completed a heliborne magnetic survey consisting of 1,994 line-km at 50m line spacings covering the entire property. The MAG survey was designed to provide geological and structural details of a 25km long southeast extension of the Confederation-Uchi greenstone belt along the Fry-Bamaji Deformation Zone.

Bear Head Gold Project
The Bear Head Gold Project comprises 31 mining claims totaling 1,944 hectares (4,800 acres) in the Meen-Dempster Greenstone Belt of the Uchi Subprovince, host to the Golden Patricia former gold mine, which produced 620,000 ounces of gold from 1988 to 1997. The Dorothy Main gold deposit owned by Ardiden lies only one kilometer from the Bear Head Gold Project. The Dorothy Main gold deposit holds noncompliant historical resources of 46,600 ounces of gold at 6.17 g/t Au. The company looks forward to adding the Bear Head Gold Project to its exploration efforts, with a work program to be conducted later in the fall of 2021.

Management Team

Mark Brezer is CEO, President, and Director of StraightUp Resources Inc. He is a successful businessman and holds a Geography/Geology degree from the University of Arizona. He has worked as a Project Manager and has overseen quality control, environmental monitoring and safety programs related to road construction. He has also held roles in media relations and marketing. He has been actively involved in the research and investment of junior mining companies for over 25 years. Time in the field and personal interest led him into extensive first aid training, and he is certified as a paramedic and firefighter.

Daniel Cruz is CFO and Director at StraightUp Resources. He is an experienced financial industry professional, having worked for 12 years as a senior investment advisor at Canadian broker-dealers, where he gained experience in equity research, asset management, investor relations, corporate finance and venture capital. He was one of the youngest Senior Investment Advisors at Canaccord Financial Inc. in 2010. He is also the co-founder and current director of Liquid Media Group Inc., a Nasdaq-listed issuer. During his tenure as CFO, he helped that company list on Nasdaq and raise over $20 million.

Matthew Coltura is a Director at StraightUp Resources. He has a Bachelor of Business Administration from Okanagan College, where he specialized in finance. He has worked in the finance industry for more than three years. Currently, Mr. Coltura is the CFO of Cayenne Capital Corp. He was also a director of PreveCeutical Medical Inc. from July 2016 to September 2019, a director of Sproutly Canada Inc. (formerly Stoneridge Exploration Corp.) from March 2015 to July 2018, and, since March 2018, has worked as a financial specialist at Quip Finance.

StraightUp Resources Inc. (OTCQB: STUPF), closed Wednesday’s trading session at $0.22755, even for the day. The average volume for the last 3 months is 200 and the stock's 52-week low/high is $0.1211/$0.27.

Recent News


The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

  • The Lightning Network has seen substantial growth during 2021, some of which is attributed to El Salvador’s adoption of BTC as legal tender
  • LQwD launched its platform November 17, while simultaneously deploying Bitcoin to ensure platform liquidity
  • Companies leveraging LQwD’s Lightning Network nodes will be able to monitor, deploy, and manage these nodes with no-to-low levels of technical expertise

One of the biggest problems described by users of the bitcoin blockchain is the slow transaction speed, right along with the fees associated with the transaction itself. The innovative Lightning Network was designed as a solution to these issues. The network is a layer 2 payment protocol that uses micropayment channels that promise faster transaction times and lower associated costs. The use of the Lighting Network helps decongest the blockchain and facilitate Bitcoin transactions. This concept was originally proposed in 2015 by Joseph Poon and Thaddeus Dryja and has been in development since. Dedicated to enabling easier access to the Lightning Network, and driving bitcoin adoption through an enterprise-grade infrastructure, financial technology company LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) recently launched a Lightning Network platform-as-a-service (“PaaS”) offering that allows users to send and receive payments instantly, securely, and inexpensively worldwide. LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. LQwD’s co-founder, chairman and CEO Shone Anstey joined the latest episode to discuss LQwD’s business model and his proven track record in the fast-moving cryptocurrency sector. “We are known as a Lightning Network service provider, or a liquidity service provider. We have a platform-as-a-service, which you can look up on our website. There, you can go in and create a Lightning Network node and payment channel,” Anstey said. “We abstract away all of the complications. You hit a button, and you can integrate the API into your system and get going on the Lightning Network very, very seamlessly. That platform is live and running… Our routing nodes help transactions get where they need to go, and, in exchange, we actually earn fees off of it… Last announced, we have 139 bitcoin on the balance sheet, and we’re continuing to put that bitcoin to use.” To view the full press release, visit

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.


The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Wednesday’s trading session at $0.40902, off by 0.469644%, on 30,827 volume with 10 trades. The average volume for the last 3 months is 30,827 and the stock's 52-week low/high is $0.25/$4.00.

Recent News

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF)

The QualityStocks Daily Newsletter would like to spotlight Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF).

  • Playgon CEO Darcy Krogh recently featured on IBN’s Bell2Bell podcast
  • PLGNF develops and licenses digital content for global iGaming market
  • Company surpassed $60 million in player betting turnover in October, up from $1.6 million in September with at least 100% growth across all key indicators
  • PLGNF’s proprietary technology enables seamless integration at operator level, allows user access without sharing sensitive data or requiring app store download

Darcy Krogh, CEO of Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), was recently featured on Bell2Bell, a podcast produced by the Investor Brand Network (“IBN”) that delivers critical updates and exclusive interviews with executives operating in hyper-growth industries (

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) is a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market. The company provides a multi-tenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table Games and Daily Fantasy Sports. Seamless integration at the operator level allows customer access without requiring the sharing of any sensitive customer data. Playgon games run on any browser and any device as fast and secure as a native app, without requiring any app store download. All that’s needed is a stable internet connection. The gaming experience is identical across all mobile devices. As a true business-to-business digital content provider, the company’s products are scalable turnkey solutions for online casinos, sportsbook operators, location-based operators, media groups, and big database companies.

Playgon’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. Playgon combines high definition live streaming dealers with state-of-the-art augmented reality betting to provide the most authentic casino experience, live from Las Vegas. Playgon’s mobile platform features popular table games, all optimized for one-handed play on mobile devices.

The COVID-19 pandemic has accelerated an already existing shift away from location-based casinos to online gambling. At the same time, the proliferation of mobile devices has provided players with new access to betting. A younger, tech-savvy consumer demographic is driving adoption of digital gaming globally. To meet this demand, Playgon has launched a studio with 10 gaming tables from which its live dealer streaming video originates. The company’s platform is live with multiple online casino operators through four aggregator clients in South Africa and Europe, and commitments are coming in from more.

Playgon plans to expand the studio to 25 tables in the near term and is working to establish a U.S. strategy. The company will continue to expand licensing of its live dealer games to iGaming operators worldwide under a SaaS license agreement. As a B2B software supplier, Playgon avoids player acquisition costs.


Live Dealer Casino

Playgon offers the first and only Live Dealer Casino streaming live from Las Vegas. The company brings cutting-edge handheld features and functionality to the mobile generation of gaming enthusiasts who demand a world-class gaming experience on all devices. Playgon’s Blackjack delivers the look and feel of location-based casino tables with features providing players with the most unique user experience. The company’s true-to-life Roulette offers players a clear and uninterrupted view of the dealer, wheel, ball, bets, results, trends and statistics. Players can strategize, place multiple bets, track results and review trends without ever losing focus of the game.

Playgon’s traditional Baccarat and proprietary Tiger Bonus Baccarat™ prove their worth by not only recognizing the need for a prominent product, but by adding elements which separate them from the pack without removing their authenticity. The games mix advances in technology with the traditional game attributes that have resonated and captivated players for hundreds of years.

eTable Games

To lead the rise of mobile-first gaming, Playgon developed a user experience perfected for one-handed play. Providing this next evolution in gaming technology ensures the company’s client operators loyalty from existing customers and is a powerful strategy to attract and retain new players. Playgon’s VEGAS LOUNGE™ brings together an innovative mix of games, technology and gameplay that offers players an authentic experience and real Las Vegas casino fun every time, everywhere.

Daily Fantasy Sports

Playgon’s Daily Fantasy Sports (DFS) are a subset of fantasy sport games which typically target a younger demographic. DFS provides iGaming operators a turnkey fantasy sports platform that can quickly go to market, integrate with the operator’s existing operations and services, and be customized to match and enhance the operator’s brand. The platform is mobile and desktop friendly, built for regulated market environments, and allows operators to monetize users through a network of shared liquidity.

Market Outlook

Online casinos and sports betting sites/apps are increasingly adding market share to traditional location-based casinos. This trend is only expected to accelerate as millennials reach their peak earning years and Gen Z youth begin to complete their education and move into careers. These generations are completely comfortable with online recreation, as well as tech like digital wallets and digital gameplay that underpins Playgon Games. The company has been described as “Netflix + Vegas, all in one.”

The online gambling market is slated to reach a value of $127.3 billion by 2027, according to Grand View Research, with much of the growth expected from the U.S. and Asia. Even Europe, the most mature gaming market, is expected to grow at a rate of 20-25 percent year over year. The current global online Live Casino TAM is estimated at about $6 billion annually, and revenue is forecast to reach more than $8 billion by 2023 and more than $13 billion by 2027.

Management Team

Darcy Krogh is CEO of Playgon Games. He is a veteran of the iGaming industry with over 20 years of experience. In 1999, he co-founded Chartwell Technology Inc., which pioneered the development of browser-based digital content for the iGaming industry. After that company was sold to Amaya Gaming Group, he served as VP Business Development with Amaya. In 2016, he started Playgon Games (formally Global Daily Fantasy Sports Inc.) as President and CEO. His experience in the online gaming industry includes sales and marketing, relationship management, corporate finance, M&A, and strategic corporate development.

Guido Ganschow is President of Playgon Interactive. He has more than 12 years of experience in creating real-time Live Dealer technology and platforms and was the co-founder and Creative Director for a Macau-based casino consortium. Between 2008 and 2014, he successfully created and established Live Dealer platform businesses in Asia and Europe, and executed commercial partnerships, sales, and integration of the Live Dealer solution with major global gaming brands, including Ho Gaming Group, Chartwell Technology and Amaya Gaming Group.

Steve Baker is COO of Playgon. He is a former VP Operations for Shaw Communications, where he was directly involved in video streaming, home entertainment, new products, sales and M&A. He oversaw revenue growth from $300 million to $2.8 billion and employee growth from 350 to 13,000. He has broad experience and a proven record in development and implementation of cost effective and efficient growth strategies transitioning businesses from development to operations.

Harry Nijjar is CFO of Playgon Games. He is currently a Managing Director with Malaspina Consultants Inc. and provides CFO and strategic financial advisory services to his clients across many industries. This experience has allowed him to help his clients successfully navigate the regulatory and financial environments within which they operate. Mr. Nijjar holds a CPA-CMA designation from the Chartered Professional Accountants of British Columbia.

Playgon Games Inc. (PLGNF), closed Wednesday’s trading session at $0.2767, even for the day. The average volume for the last 3 months is 21,175 and the stock's 52-week low/high is $0.197/$1.32.

Recent News

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF)

The QualityStocks Daily Newsletter would like to spotlight Mydecine Innovations Group Inc. (MYCOF).

  • Mydecine’s recent Q3 update includes the company’s five-year research agreement with Johns Hopkins University School of Medicine, which will cover clinical research related to the therapeutic use of psychedelics
  • Mydecine has also filed for various patents on proprietary compounds within the company’s IP portfolio
  • In addition, an updated version of the company’s virtual health platform, Mindleap 2.0, was released in Q3, enhancing user experience, infrastructure improvement, and expansion of overall content

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA), a company that focuses on bio- and digital technology that aims to transform the treatment of mental health and addiction disorders, has released financials and a business update for the third quarter ending September 30, 2021 ( The highlight of this quarter was the five-year research agreement Mydecine Innovations entered with Johns Hopkins University School of Medicine, one of the most experienced university departments in conducting clinical research related to the therapeutic use of psychedelics, according to CEO Joshua Bartch. Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, recently filed a patent application covering bioavailability-enhancing, nanoemulsion-empowered formulations. The move followed on the heels of a previous announcement that the company had filed a final patent application for MYCO-003, one of its lead drug candidates. Nanoemulsion is an advanced drug delivery system that offers enhanced stability, fast digestibility, controlled release and protection against degradation. “Specifically, Mydecine is targeting the enhanced bioavailability and controlled capabilities of the nanoemulsion technology. The system’s controlled-release capability, for example, will be instrumental in the company’s active drug development by aiding in micro-dosing and customizing dosages,” reads a recent article. “Through its latest technology patent filing, coupled with the September final patent application, the company is steadily strengthening its intellectual property (‘IP’) portfolio as it seeks to reimagine mental health and addiction treatment with safer, more effective solutions.” To view the full article, visit:

Mydecine Innovations Group Inc. (NEO: MYCO) (NASDAQ: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health disorders and addiction. Founded in 2020 on the guiding principle that there is a significant unmet need and lack of innovations in the mental health and therapeutic treatment environments, Mydecine is dedicated to efficiently developing innovative first- and second-generation novel therapeutics to treat PTSD, addiction and other mental health disorders.

Mydecine’s business model combines clinical trials and data outcome, technology and scientific and regulatory expertise with a focus on psychedelic therapy underpinned by novel molecules with differentiated therapeutic potential. By collaborating with some of the world’s foremost authorities connected by best practices, Mydecine aims to responsibly fast-track the development of new medicines across its platforms, ultimately changing the way we treat mental health disorders. The company seeks to bridge the gap between the needs of patients and what the mental health care system currently provides.

Mydecine Innovations Group is headquartered in Denver with international offices in Canada and Europe.

Research and Technology

The invention and development of novel psychedelic and non-psychedelic molecules for medical use is an important part of Mydecine’s research strategy. The company uses molecules found in nature as building blocks to create improved second-generation drugs. This portfolio of new drugs represents major improvements to existing natural products and synthetics, including enhanced safety, efficacy, stability and dosing, as well as reduced side effects.

The goal of creating these improved second-generation compounds is to enable safer, more effective treatments for patients, along with improved management of dosage and drug behavior for clinicians. Mydecine believes the multibillion-dollar market for mental health and addiction disorder medicines will soon be disrupted amid a resurgence of the study into psychedelics and data showing the immense benefits of these forms of medicine.

The company currently has four lead drug candidates which include various enhancements such as improved controllability, delivery mechanisms, safety, stability and shelf-life. The drug candidates are in clinical trials or in pre-trial stage as potential treatments to aid PTSD, substance abuse and smoking cessation.

Mindleap Health is a wholly owned subsidiary of Mydecine. The Mindleap platform is a virtual community that aims to foster the conscious and responsible adoption of psychedelic medicine into inner wellness. Users access the platform through the Mindleap app. Mindleap provides users with inner wellness resources to assist them in their daily mental-health journeys. The platform also seeks to support the conscious and trustworthy adoption of psychedelics into a widely accepted approach to mental health and inner wellness.

Market Outlook

The global smoking cessation market is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9 percent from 2018 to 2026. The market for psychedelic therapeutics is in its very early stages. Estimates of current market value and forecasts of expected value in future years are all over the map. Market forecasts range from $6.5 billion by 2030 with a CAGR of 15 percent, to more than $69 billion as soon as 2025, at a CAGR of 8.2 percent. What is clear is that interest in psychedelic therapeutic drugs is expanding rapidly.

Management Team

Joshua Bartch is Chief Executive Officer and Chairman of Mydecine Innovations Group. He is an experienced entrepreneur who co-founded and founded Denver-based dispensary Doctors Orders in 2009. He also founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Bartch co-founded, the USA’s most significant and sophisticated legal cannabis wholesale platform.

Dr. Rakesh Jetly, OMM, CD, MD, FRCPC, is the Chief Medical Officer of Mydecine. He was formerly Chief of Psychiatry for the Canadian Armed Forces, retiring in 2021 with the rank of colonel after 31 years of service. He began his career as a general duty medical officer and flight surgeon and spent his final 20 years of service as a psychiatrist. He maintains academic appointments at Dalhousie University and The University of Ottawa. He is the inaugural CF Brigadier Jonathan C. Meakins CBE, RCMAC, Chair in Military Mental Health at the Royal Ottawa Hospital.

Robert Roscow is Chief Scientific Officer of Mydecine. As a geneticist, he has spent his academic and professional careers looking for valuable and unique medicinal molecules found in nature. His innovations were applied at Canopy Growth and ebbu, where he ran those companies’ genetics divisions. He has leveraged his expertise to maximize industrial production of cannabinoids in a pharmacological context, resulting in multiple patent filings.

Damon Michaels is Chief Operating Officer of Mydecine. He previously consulted for various hemp businesses through his company, Emerald Baron. Before that, he served as GM for ebbu, the leading multi-platform cannabinoid research and technology firm based in Colorado. He has held leading roles with multiple large brands throughout the cannabis vertical. He also developed a national snowboard brand.

Mydecine Innovations Group Inc. (MYCOF), closed Wednesday’s trading session at $0.145, even for the day, on 478,984 volume with 146 trades. The average volume for the last 3 months is 478,984 and the stock's 52-week low/high is $0.1356/$2.20.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading